Gateway 2012: AdvantaPure - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: AdvantaPure


AdvantaPure®
145 James Way, Southampton, PA 18966
Phone 888-599-6099 or 215-526-2151
Fax 888-258-4293 or 215-526-2167
pt@advantapure.com
www.advantapure.com

Company Description:

AdvantaPure®, the high purity products division of NewAge® Industries, is designed to anticipate and meet the evolving needs of the pharmaceutical manufacturing industry. AdvantaPure is ISO 9001:2008 certified, and many of its products meet USP Class VI, FDA, ISO, and European Pharmacopoeia standards.

AdvantaPure’s tubing and hose includes AdvantaFlex® biopharmaceutical grade pump tubing, platinum cured silicone tubing and reinforced hose, and reinforced PTFE, FEP, and EPDM hose. The company focuses on single use manifold assemblies and manufactures both molded manifolds and assembled tubing sets. A variety of attachments allow for complete, ready-to-use systems. Gamma irradiation services are available.

Molded manifold connections eliminate many barbed fitting connections and their leak potentials.

Silicone, fluoropolymer and TPE tubing.

Booth Invitation:

Discover AdvantaPure’s tubing and hose products at Interphex booth 3055. Standards like silicone, TPE, and fluoropolymer tubing will be on hand as well as other products in development. Compare the advantages of single use molded manifold connections vs. barbed fittings and cable ties, plus see the new AdvantaTube Sealer and AdvantaTube Sterile Welder for TPE tubing in action.

Additional Information:
AdvantaFlex® TPE Now Available as Molded Components
The New AdvantaTube Sealer & Sterile Welder Available Now
Comparative Advantages of Molded Manifolds

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here